Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 05-2023 | 02-2023 | 11-2022 | 08-2022 | 05-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,091 | 2,950 | 6,830 | 4,222 | 991 |
| Receivables | 29,024 | 32,371 | 35,689 | 40,934 | 40,094 |
| Inventories | 40,841 | 48,696 | 77,524 | 64,285 | 44,300 |
| Other current assets | 0 | 0 | 0 | 0 | 33,144 |
| TOTAL | $93,875 | $88,439 | $127,092 | $116,598 | $123,712 |
| Non-Current Assets | |||||
| PPE Net | 134,390 | 120,799 | 118,852 | 117,551 | 115,031 |
| Intangibles | 18,081 | 18,281 | 22,573 | 23,927 | 18,581 |
| Other Non-Current Assets | 7,199 | 8,634 | 10,556 | 11,022 | 20,482 |
| TOTAL | $159,670 | $147,714 | $151,981 | $152,500 | $154,094 |
| Total Assets | $253,545 | $236,153 | $279,073 | $269,098 | $277,806 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 580 | N/A | 146,953 | 142,569 | 138,178 |
| Accounts payable and accrued liabilities | 22,097 | 14,762 | 27,971 | 16,366 | 12,988 |
| Accrued Expenses | 4,145 | 6,733 | 4,602 | 6,373 | 8,941 |
| TOTAL | $39,289 | $37,673 | $195,696 | $178,964 | $176,810 |
| Non-Current Liabilities | |||||
| Long Term Debt | 165,965 | 114,964 | N/A | 0 | N/A |
| Deferred Revenues | 4,055 | 2,711 | 731 | 803 | 919 |
| Other Non-Current Liabilities | 9,883 | 10,719 | 9,200 | 9,646 | 10,173 |
| TOTAL | $179,168 | $125,763 | $9,210 | $9,770 | $10,299 |
| Total Liabilities | $218,457 | $163,436 | $204,906 | $188,734 | $187,109 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 30,322 | 30,319 | 30,319 | N/A |
| Common Shares | 30 | 30 | 30 | 30 | 30 |
| Retained earnings | -178,536 | -140,091 | -99,899 | -87,450 | -76,099 |
| Other shareholders' equity | 39,318 | 38,510 | 0 | -286 | -586 |
| TOTAL | $35,088 | $72,717 | $74,167 | $80,364 | $90,697 |
| Total Liabilities And Equity | $253,545 | $236,153 | $279,073 | $269,098 | $277,806 |